EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Treatment Patterns of Oral Glucocorticoids in Patients with IgG4-Related Disease: A Real-World Analysis based on a Japanese Claims Database

Mitsuhiro Kawano iD, Hirokazu Sato iD, Masamichi Yamamoto, Nagisa Takashima, Yoshiko Ikawa, Yoshie Hongo, Kazuichi Okazaki

Modern Rheumatology · 07.11.2026

DOI: 10.1093/mr/roag097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Rheumatology, online erschienen am 07.11.2026. Verfasst von Mitsuhiro Kawano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Immunology, Kanazawa Medical University, Ishikawa, Japan. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To describe the prescribing patterns of oral glucocorticoid and evaluate flares and glucocorticoid-related complications in patients with immunoglobulin G4-related disease.

Methods

This retrospective observational study used a Japanese hospital claims database. Patients with a prescription for oral glucocorticoids, a diagnosis of immunoglobulin G4-related disease, and having at least two immunoglobulin G4 measurement tests were included. The index date was defined as the first oral glucocorticoid prescription recorded in the database (Day 0). Patients were followed for up to Day 1460 (4 years).

Results

The study included 3,167 patients. The mean dose of oral glucocorticoid was 28.76, 10.71, and 4.12 mg/day on Day 0, 90, and 1095, respectively. At Day 1460, 66.56% of the patients were still receiving oral glucocorticoid therapy and the dose exceeded 5 mg/day in 17.80% of patients. During the follow-up period, 453 patients (14.30%) experienced at least one flare. The incidence rates of hospitalized infections, osteoporotic fractures, and cardiovascular diseases, defined as serious glucocorticoid complications, were 7.46, 0.61, and 1.61 per 100 person-years, respectively.

Conclusions

Over half of the patients continued glucocorticoid therapy at 4 years. Glucocorticoid withdrawal strategies could be associated with reducing the long-term glucocorticoid-related toxicity in patients with immunoglobulin G4-related disease.

Schlagwörter

Stichwörter der Autor:innen

Claims databaseComplicationsFlareGlucocorticoidIgG4-related diseaseMaintenance therapyPrednisoloneReal-world data

Autor:innen und Institutionen

  • Department of Hematology and Immunology, Kanazawa Medical University, Ishikawa, Japan.
  • Medical Affairs Department, Development & Medical Affairs Division, Tanabe Pharma Corporation, Tokyo, Japan.
  • Data Science Department, Development & Medical Affairs Division, Tanabe Pharma Corporation, Tokyo, Japan.
  • Department of Internal Medicine, Kansai Medical University Kori Hospital, Osaka, Japan.

ORCID-Profile: Mitsuhiro Kawano, Hirokazu Sato

Zitieren

APA

Kawano, M., Sato, H., Yamamoto, M., Takashima, N., Ikawa, Y., Hongo, Y., & Okazaki, K. (2026). Treatment Patterns of Oral Glucocorticoids in Patients with IgG4-Related Disease: A Real-World Analysis based on a Japanese Claims Database. Modern Rheumatology. https://doi.org/10.1093/mr/roag097

Vancouver

Kawano M, Sato H, Yamamoto M, Takashima N, Ikawa Y, Hongo Y, et al. Treatment Patterns of Oral Glucocorticoids in Patients with IgG4-Related Disease: A Real-World Analysis based on a Japanese Claims Database. Modern Rheumatology. 2026. doi:10.1093/mr/roag097

BibTeX
@article{Kawano2026,
  author = {Kawano, Mitsuhiro and Sato, Hirokazu and Yamamoto, Masamichi and Takashima, Nagisa and Ikawa, Yoshiko and Hongo, Yoshie and Okazaki, Kazuichi},
  title = {Treatment Patterns of Oral Glucocorticoids in Patients with IgG4-Related Disease: A Real-World Analysis based on a Japanese Claims Database},
  journal = {Modern Rheumatology},
  year = {2026},
  doi = {10.1093/mr/roag097}
}
Kostenlos starten →